Furthering the evidence-based management of dermatologic effects of EGFR inhibitor therapy Supriya KoyaChandra Kumar ShanmugamJames A. Posey Clinical Trials Report 13 October 2009 Pages: 179 - 181
Vitamin D analogues in colon cancer prevention and care Marcy E. BeildeckStephen W. Byers OriginalPaper 13 October 2009 Pages: 185 - 196
Wip1, an oncogene targeting tumor suppressors expressed in intestinal stem cells Oleg N. DemidovHyukjin ChaAlbert J. Fornace Jr OriginalPaper 13 October 2009 Pages: 197 - 202
Is telomerase a novel target for metastatic colon cancer? Andres I. RoigWoodring E. WrightJerry W. Shay OriginalPaper 13 October 2009 Pages: 203 - 208
New therapeutics targeting colon cancer stem cells Arun ThenappanYing LiLopa Mishra OriginalPaper 13 October 2009 Pages: 209 - 216
Optimizing rectal cancer surgery by total mesorectal excision and “cylindrical” extralevator techniques for abdominoperineal excision Katharine E. BevanBrendan J. Moran OriginalPaper 13 October 2009 Pages: 219 - 223
Imaging for staging and response assessment in rectal cancer Samanjit HareVicky Goh OriginalPaper 13 October 2009 Pages: 224 - 231
Choosing between short-course preoperative radiotherapy and long-course chemoradiation therapy David Sebag-MontefioreGanesh Radhakrishna OriginalPaper 13 October 2009 Pages: 232 - 239
Are there alternatives to radical surgery in rectal cancer? Robert HughesCarie CornerRobert Glynne-Jones OriginalPaper 13 October 2009 Pages: 240 - 246